Gene delivery strategies targeting stable atheromatous plaque.
Conventional therapeutic options to treat chronic angina pectoris are pharmacological interventions, coronary bypass surgery (CABG) and percutaneous coronary intervention (PCI). In animal models, it was shown that gene delivery strategies harbour an exciting potential to support and maybe even repla...
Κύριοι συγγραφείς: | Van-Assche, T, Huygelen, V, Crabtree, M, Antoniades, C |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
2013
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Gene therapy targeting inflammation in atherosclerosis.
ανά: Van-Assche, T, κ.ά.
Έκδοση: (2011) -
Targeting vascular redox biology through antioxidant gene delivery: a historical view and current perspectives.
ανά: Van Assche, T, κ.ά.
Έκδοση: (2011) -
Periodontal pathogens in atheromatous plaque
ανά: Saroj K. Rath, κ.ά.
Έκδοση: (2014-01-01) -
Macrophages in Atheromatous Plaque Developmental Stages
ανά: Alexander von Ehr, κ.ά.
Έκδοση: (2022-04-01) -
Letter to the Editor. Atheromatous Plaque Vulnerability — the Neglected Vulnerable Carotid Plaques
ανά: Péter Levente
Έκδοση: (2017-09-01)